Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Biocardia Inc. buy me8

Biocardia Inc.
Start price
€4.53
14.12.20 / 50%
Target price
€5.00
14.12.21
Performance (%)
-24.50%
End price
€3.42
29.01.21
Summary
This prediction ended on 29.01.21 with a price of €3.42. The prediction for Biocardia Inc. disappointed with a performance of -24.50%. me8 has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Biocardia Inc. - - - -
iShares Core DAX® 0.734% 1.458% 17.980% 65.292%
iShares Nasdaq 100 -2.686% -0.146% 3.810% 97.467%
iShares Nikkei 225® -2.261% -2.729% 11.679% 39.755%
iShares S&P 500 -1.346% 0.467% 1.970% 61.093%

According to me8 what are the pros and cons of Biocardia Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
Cons
high free float

Comments by me8 for this prediction

In the thread Biocardia Inc. diskutieren
Prediction Buy
Perf. (%) -24.50%
Target price 5.000
Change
Ends at 14.12.21

Buy mit Kursziel 5,0

me8 
0
Report Share
14.12.20
In the thread Trading Biocardia Inc.
Prediction Buy
Perf. (%) -24.50%
Target price 5.000
Change
Ends at 14.12.21

Buy beendet

me8 
0
Report Share
29.01.21

Stopped prediction by me8 for Biocardia Inc.

buy
Biocardia Inc.

Start price
Target price
Perf. (%)
€0.81
15.11.23
-
15.11.24
-56.52%
16.11.24

Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
high free float
me8 
15.11.23 0%